The Novasep-PharmaZell Group has announced a €7.3M (approximately $7.45 USD) investment for its Mourenx, France site as part of a...
Read moreWhen the epidemic subsides, Alkem Laboratories predicts that inflationary pressures and shifting regulatory standards will be the primary concerns to...
Read moreLonza, a major CDMO, is to invest $518 million in a new, massive fill-finish manufacturing facility in Stein, Switzerland. According...
Read morePfizer and another pharmaceutical major, Touchlight, have come to a deal on a significant non-exclusive patent licence. Touchlight is a...
Read moreThe standard response to any poor performance is to blame the supply chain, which has almost attained the status of...
Read moreAccording to the third Real-World Evidence (RWE) benchmarking survey published in June 2022 by Deloitte, there is a segmentation of...
Read moreThe Paris-based pharmaceutical company is setting up a fund to assist companies who want to provide healthcare solutions in neglected...
Read moreThe oral, once-daily Zejula (niraparib) tablet, a first-line and recurrent upkeep care for women with advanced epithelial high-grade ovarian, fallopian...
Read moreAbbott informed yesterday, July 3rd, that there are several ways to tell if a customer's pack of Thyronorm is authentic...
Read moreRecent market analysis predicts that the international market for biopharmaceutical bioseparation systems, which is expected to be worth $13 billion...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.